Differences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomas-Reference-Cited by-同舟云学术

Differences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomas

Published:2018-10 Issue:4 Volume:156 Page:1679-1688.e2
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Katsumata Shinya,Aokage Keiju,Miyoshi Tomohiro,Tane Kenta,Nakamura Hiroshi,Sugano Masato,Kojima Motohiro,Fujii Satoshi,Kuwata Takeshi,Ochiai Atsushi,Hayashi Ryuichi,Tsuboi Masahiro,Ishii Genichiro

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference35 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer;Travis;J Thorac Oncol,2016

3. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease;Kadota;Am J Surg Pathol,2014

4. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases;Yoshizawa;Mod Pathol,2011

5. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers;Asamura;J Thorac Oncol,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic implications, genomic and immune characteristics of lung adenocarcinoma with lepidic growth pattern;Journal of Clinical Pathology;2024-08-03

2. Single-cell analyzing of tumor microenvironment and cell adhesion between early and late-stage lung cancer;Molecular Immunology;2024-07

3. Unveiling neoadjuvant chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing;2024-05-09

4. Unveiling neoadjuvant chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing;2024-05-09

5. Unveiling neoadjuvant chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing;2024-02-21